• vcard
D 202.626.8313
F 202.626.8372
  • Education
    • J.D., Harvard Law School, 1994
    • M.D., Duke University Medical School, 1990
    • B.S.M.E., Duke University, 1986
Steven Stranne is a physician and lawyer with over 25 years of experience in Washington, D.C., designing, implementing, and overseeing complex legislative and regulatory initiatives involving Congress, the Centers for Medicare & Medicaid Services (CMS), the Food and Drug Administration (FDA), numerous other federal agencies within the U.S. Department of Health and Human Services (HHS), and the Medicare Administrative Contractors.

He currently serves as policy counsel to numerous health care providers and manufacturers of pharmaceuticals, biologics, and medical devices.

Steve helps clients develop and implement strategies to secure appropriate reimbursement, coding, and coverage policies for new and existing medical technologies and clinical services. He works on behalf of manufacturers and associations before the FDA.  Steve also works with the boards and leadership of manufacturers, health care providers, and associations to assist with strategic planning amid the evolving regulatory and reimbursement landscape for health care services, drugs, and devices.

He provides unique experience in shaping public policy. He works to develop novel strategies for clients to achieve their objectives, combining his abilities to understand the health care sector and interpret and help shape clinical literature, legislation, and federal regulations.

Additionally, Steve often serves as the primary contact for health care clients on a range of advocacy and legal issues, including government relations, contracting, and compliance with the federal and state laws governing fraud, abuse, and waste. He is particularly effective in discussing and presenting complex substantive issues to policy makers, including clinical issues to medical professionals within the federal agencies and Medicare contractors.

His practice includes representing clients before the:
  • Centers for Medicare & Medicaid Services
  • Food and Drug Administration
  • U.S. Congress
  • Medicare carriers
  • Durable Medical Equipment Medicare Administrative Contractors (DME MACs, formerly the DMERCs)
  • HCPCS Workgroup (for securing new and revised HCPCS codes)
  • AMA CPT Panel (for securing new and revised CPT codes)
  • Medicare's Pricing Data Analysis and Coding (PDAC) Contractor 
  • Medicare's Inpatient and Outpatient Hospital Programs for new, innovative technologies,drugs and biologics (NTAP and Pass-Through)
  • Worked to shape important aspects of every piece of federal legislation involving Medicare provisions since the Balanced Budget Act of 1997.
  • Provided comments and otherwise worked to shape the regulations, manuals, and guidance issued by the federal agencies overseeing health care issues including Centers for Medicare & Medicaid Services (CMS), the Food and Drug Administration (FDA), and the National Institutes of Health (NIH).
  • Secured changes in coding, reimbursement, and coverage policies at the national level under the Medicare program for professional services, medical devices, drugs, biologics, orthotics, prosthetics, durable medical equipment, and other items.
  • Assisted manufacturers and nonprofit organizations in the health care field with respect to evolving trends in federal policy development.
  • Drafted proposals for federal and state legislation.
  • Developed comprehensive strategies for enacting legislation and educating agency officials at both the federal and state levels.
text icon Publications & Presentations
Co-Host, In-House Influence Podcast, Washington, D.C.
December 2020
eAlerts Updates
April 24, 2016
eAlerts Updates
February 22, 2016
eAlerts Updates
October 30, 2015
text icon Publications & Presentations
Nothing is as Constant as Change: Adapting Clinical Trials Management under the Affordable Care Act
5th Annual Meeting of the American Association of Cancer Institutes’ Clinical Research Initiative
Presentation given in Chicago, Illinois
July 11, 2013
text icon Publications & Presentations
Pricing Challenges and Evolving Federal Policies: Health Reform and Beyond
American Conference Institute’s 11th National Prescription Drug Pricing Boot Camp
Presentation given in San Francisco, California

June 19, 2013
text icon Publications & Presentations
The Affordable Care Act: Legislative Update and What to Expect in Oncology
2013 Annual Meeting of the American Society of Clinical Oncology
Presentation given in Chicago, Illinois

June 3, 2013
text icon Publications & Presentations
Health Policy Commentary: Protecting Patient Access to Oral Cancer Drugs in the United States
Journal of Oncology Practice
Published online ahead of print

May 21, 2013
text icon Publications & Presentations
Affordable Care Act: What is Next?
American Lung Association's 2013 Healthy Lung Expo
Presentation given in Chicago, Illinois.
May 3, 2013
text icon Publications & Presentations
Reimbursement Strategies: A Plan for Innovators in the Life Sciences
The 2nd Annual Medical Entrepreneur Symposium
Presentation given in Delray, Florida.
April 20, 2013